CROI 2016

infohep news

• HBV treatment for people with HIV

  HIV/HBV co-infection linked to worse immune recovery and death, but tenofovir improves outcomes

  Liz Highleyman / 12 April 2016

  HIV-positive people with hepatitis B virus (HBV) co-infection had impaired CD4 cell recovery after starting antiretroviral therapy (ART) and a higher risk of death than those without hepatitis B, but use of ...

• Treatment for people living with HIV and HCV

  Sofosbuvir/velpatasvir for hepatitis C can be administered with most antiretrovirals

  Liz Highleyman / 11 March 2016

  Sofosbuvir/velpatasvir, a forthcoming combination that effectively treats all hepatitis C virus (HCV) genotypes, can be safely used with most boosted antiretrovirals for people with HIV and HCV co-infection, according to a study presented ...

• Genotype 4

  Ravidasvir plus sofosbuvir demonstrates high cure rate for people with hepatitis C genotype 4

  Liz Highleyman / 02 March 2016

  Sofosbuvir plus the investigational HCV NS5A inhibitor ravidasvir, with or without ribavirin, cured 95 to 100% of people with hepatitis C virus (HCV) genotype 4, the most common type in Egypt, ...

• Treatment for people living with HIV and HCV

  Sofosbuvir/ledipasvir for 6 weeks cures HCV in HIV-positive people with acute HCV if viral load is low

  Liz Highleyman / 26 February 2016

  An interferon- and ribavirin-free regimen of sofosbuvir/ledipasvir (Harvoni) taken for just 6 weeks was enough to cure hepatitis C in HIV-positive people with recent hepatitis C virus (HCV) infection if their HCV viral ...